Delivery Order SPE2DB22D3301-SPE2DB26FX4MX
- Not listed
- The Defense Logistics Agency awarded a $2,281.50 delivery order (Contract 4569866241) to AmerisourceBergen Drug Corp on October 29, 2025, for ALBUKED-25 VIAL 100ML pharmaceutical supplies. The contract employs firm fixed-price pricing with an ultimate completion date of November 20, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,320.60 to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML pharmaceutical products on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,368.90 to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML pharmaceutical product on September 26, 2025, with completion expected by October 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a $1,131.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of ALBUKED-25 vial 50ML pharmaceutical product. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 1, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,140.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of ALBUKED-25 vials in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of October 10, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically ALBUKED-25 VIAL 100ML, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 3, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,281.50 by the Defense Logistics Agency on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract calls for the delivery of Albuked-25 vial 100ml to support federal medical procurement needs. The delivery order is classified as a child contract under a larger indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.50 to AmerisourceBergen Drug Corp for ALBUKED-25 Vial 100ML on November 7, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.00 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 Vial 50ML on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed price, non-set-aside delivery order represents a pediatric pharmaceutical product delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4MXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,563.00 to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML pharmaceutical supplies. This non-competitive delivery order, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant prime IDC valued at $999,999,999.00 through December 2026 that serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order exemplifies AmerisourceBergen's role as a critical federal medical procurement vendor for Defense Department healthcare systems. The contractor's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. As part of DLA's strategic approach to pharmaceutical procurement, AmerisourceBergen competes alongside other prime vendors to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet medical supply needs across global military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 11/7/25 |